CHICAGO (GenomeWeb) – Children's Hospital Los Angeles will implement Edico Genome's Dragen Bio-IT platform to help the hospital expand genome-based testing for children with cancer and various genetic disorders, Edico said today.

Children's LA has already validated the Dragen Germline pipeline, Edico Genome said. The pediatric facility will now adopt other elements of the Bio-IT platform. This includes reviewing the Dragen Somatic pipeline for whole-exome sequencing of cancer samples and the RNA Seq pipeline for fusion detection, according to the technology vendor.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.